Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 22,820
+210 (0.93%)
Sep 22, 2026, 11:30 AM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 289.96 billion as of September 21, 2026. Its market cap has increased by 40.00% in one year.
Market Cap
289.96B
Enterprise Value
292.21B
Revenue
23.72B
Ranking
n/a
PE Ratio
58.25
Stock Price
22,820.00
ChartMarket Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 289.96B, an increase of 86,420.52%. That is a compound annual growth rate of 30.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 293.49B | 50.59% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 509.84B |
| Gland Pharma | 488.61B |
| Ajanta Pharma | 445.22B |
| Emcure Pharmaceuticals | 380.08B |
| Wockhardt | 338.97B |
| Piramal Pharma | 276.70B |
| Eris Lifesciences | 183.09B |
| Alivus Life Sciences | 175.62B |